Free shipping on all orders over $ 500

CCF642

Cat. No. M8686

All AbMole products are for research use only, cannot be used for human consumption.

CCF642 Structure
Size Price Availability Quantity
5mg USD 75 In stock
10mg USD 110 In stock
25mg USD 230 In stock
50mg USD 380 In stock
100mg USD 550 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CCF642 is a cell-permeable protein disulfide isomerase (PDI) inhibitor that exhibits 100-fold higher potency than PACMA 31 (by di-E-GSSG assay) via an alternative mode of action that most likely involves PDI active-site CGHCK motifs instead of cysteine known to be targeted by PACMA 31. CCF642 displays anti-multiple myeloma (MM) activity both in cultures in vitro (IC50 <1 μM against murine 5TGM1 and nine human MM lines) and in mice in vivo (10 mg/kg, 3X i.p. per wk) without apparent adverse effects to the animals or being cytotoxic to normal bone marrow (NLBM) cells even at concentrations as high as 6.75 μM. Consistent with PDI′s role in ER protein folding process, CCF642 treatment causes acute ER stress accompanied by apoptosis-inducing calcium release in MM cells.

Chemical Information
Molecular Weight 378.45
Formula C15H10N2O4S3
CAS Number 346640-08-2
Form Solid
Solubility (25°C) DMSO: 5 mg/mL (warmed)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Metis Hasipek, et al. Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma

[2] Xiaohan Gao, et al. Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH/Bcl-2/caspase-3 pathway

[3] Maryam Kamarehei, et al. Inhibition of protein disulfide isomerase has neuroprotective effects in a mouse model of experimental autoimmune encephalomyelitis

[4] Sergei Vatolin, et al. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma

Related Apoptosis Products
23-Hydroxybetulinic acid

23-Hydroxybetulinic acid is a novel anticancer substance.

TH-302 (Evofosfamide)

TH-302 is a highly potent and selective hypoxia-activated procompound targeting hypoxic regions of solid tumors with IC50 of 19 nM.

Se-Methylselenocysteine

Se-methylselenocysteine, a precursor of methyl selenium, has strong cancer chemoprophylaxis and antioxidant activity. Se-Methylselenocysteine has oral biological activity, can induce apoptosis.

Aloperine

Aloperine is exhibits anti-inflammatory, antibacterial, antiviral, and anti-tumor properties.

Ezatiostat

Ezatiostat (TER199, TLK199) is a glutathione analog inhibitor of glutathione S-transferase (GST) P1-1. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation.

  Catalog
Abmole Inhibitor Catalog




Keywords: CCF642 supplier, Apoptosis, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.